| Gene Symbol | ent-gene-69e4f0e3 |
| Approach | Mechanism |
| P2X7 antagonists | Block ATP binding and channel activation |
| P2X7 agonists | May cause receptor desensitization |
| Allosteric modulators | Modulate channel gating kinetics |
| Compound | Company |
| AZD9056 | AstraZeneca |
| CE-224535 | Pfizer |
| JNJ-4796559 | Janssen |
| GW-791343 | GlaxoSmithKline |
| KX1-041 | Klexeon |
| ATL-004 | Artelo |
| Combination | Rationale |
| P2X7 antagonist + NLRP3 inhibitor | Complete inflammasome blockade |
| P2X7 antagonist + IL-1β antibody (canakinumab) | Target cytokine directly |
| P2X7 antagonist + anti-TNF therapy | Broader immune modulation |
| KG Connections | 2 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |